Literature DB >> 21169252

The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally.

William S Dalton1, Daniel M Sullivan, Timothy J Yeatman, David A Fenstermacher.   

Abstract

The Patient Protection and Affordable Care Act of 2010 will have a profound influence on health care in the United States, including how we conduct cancer research and cancer care delivery. For this reason, oncologists and researchers must be intimately involved in the implementation and interpretation of this important legislation. A major goal of the Act is to improve access to affordable, quality health care. An important element in achieving this goal will be to learn from patients' experiences and build the foundation for evidence-based personalized medicine. This will require a partnership among researchers, clinicians, policy makers and regulators, and patients to design an integrated information network system that will be the basis for providing the right treatment for the right patient in the right place at the right time. In this review, we will discuss the salient points of the Act that specifically affect cancer research and care, as well as highlight opportunities for oncologists and researchers to play a primary role in developing a health care system that includes personalized medicine approaches that will in turn enhance the likelihood of achieving the goals and objectives of the health care reform act. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 21169252     DOI: 10.1158/1078-0432.CCR-10-1216

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  6 in total

Review 1.  Implementing personalized medicine in a cancer center.

Authors:  David A Fenstermacher; Robert M Wenham; Dana E Rollison; William S Dalton
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

2.  The impact of insurance on access to cancer clinical trials at a comprehensive cancer center.

Authors:  Justin F Klamerus; Suanna S Bruinooge; Xiaobu Ye; Mandi L Klamerus; Dorothy Damron; Dina Lansey; John C Lowery; Luis A Diaz; Jean G Ford; Norma Kanarek; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

3.  Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.

Authors:  Rhonda Greenapple
Journal:  Am Health Drug Benefits       Date:  2012-07

4.  Collaborative biomedicine in the age of big data: the case of cancer.

Authors:  Abdul R Shaikh; Atul J Butte; Sheri D Schully; William S Dalton; Muin J Khoury; Bradford W Hesse
Journal:  J Med Internet Res       Date:  2014-04-07       Impact factor: 5.428

5.  Patient Enrichment for Precision-Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials.

Authors:  William S Dalton; Daniel Sullivan; Jeffrey Ecsedy; Michael A Caligiuri
Journal:  Clin Pharmacol Ther       Date:  2018-03-23       Impact factor: 6.875

6.  Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea.

Authors:  Jong-Myon Bae
Journal:  J Prev Med Public Health       Date:  2017-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.